… coronavirus 2 (SARS-CoV-2) … of SARS-CoV-2 in late 2019 was followed by a period of
relative evolutionary stasis lasting about 11 months. Since late 2020, however, SARS-CoV-2 …

… coronavirus 2 (SARS-CoV-2) exhibited a major step change in its adaptation to humans.
These highly mutated forms of SARS-CoV-2 … and antigenicity of SARS-CoV-2 variants, the role …

… been identified from SARS-CoV-2 convalescent individuals and … SARS-CoV-2 and
human humoral immunity. Indeed, we showed that Omicron would escape most of the SARS-CoV-2 …

… to antibodies used for COVID-19 treatment. Moreover, entry of … COVID-19 patients and sera
from BNT162b2-vaccinated individuals. These results suggest that SARS-CoV-2 may escape …

… infected by SARS-CoV-2 original strain … SARS-CoV-2 variant Omicron S protein with a
large number of mutations has an outstanding effect on the viral infectivity and immune escape …

The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
began when the first sequence was published, and this forms the basis for …

… To select SARS-CoV-2 S variants that escape neutralization by antibodies, we used a …
encodes the SARS-CoV-2 spike (S) protein and green fluorescent protein (rVSV/SARS-CoV-2/GFP…

… samples from COVID-19 vaccine recipients or individuals who have recovered from COVID-19.
… Sera from COVID-19-convalescent patients collected 6 or 12 months after symptoms …

… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in … neutralizing plasma from a
COVID-19 convalescent patient. … suggests that SARS-CoV-2 has the potential to escape an …

… 10 globally circulating strains of SARS-CoV-2. Five of the 10 … SARS-CoV and bat-derived
WIV1-CoV, suggesting that a relatively small number of mutations can mediate potent escape …